Comparing Estradiol / Norethindrone / Relugolix vs Orilissa
| Estradiol / norethindrone / relugolix | Orilissa (elagolix) |
|
|---|
| Estradiol / norethindrone / relugolix | Orilissa (elagolix) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Uterine Fibroids, Endometriosis. Estradiol / norethindrone / relugolix may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Endometriosis. Orilissa may also be used for purposes not listed in this medication guide. |
Related suggestions Endometriosis
|
|||||||
| More about Estradiol / norethindrone / relugolix | More about Orilissa (elagolix) | ||||||||
| Ratings & Reviews | |||||||||
|
Estradiol / norethindrone / relugolix has an average rating of 7.9 out of 10 from a total of 14 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 7% reported a negative effect. |
Orilissa has an average rating of 5.4 out of 10 from a total of 128 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 40% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Orilissa side effects |
|||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Orilissa prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Myfembree |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
60.8 hours |
6 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 645 drugs are known to interact with Estradiol / norethindrone / relugolix:
|
A total of 371 drugs are known to interact with Orilissa:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
|
|||||||||
| First Approval Date | |||||||||
|
May 26, 2021 |
July 23, 2018 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.